SCHEMBL23933214

SCHEMBL23933214

CCCc1cc(O)n2nccc2n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK7 P50613 2/20 0.49
CDK9 P50750 2/20 0.49
CDK2 P24941 1/20 0.49
CDK13 Q14004 1/20 0.49
CDK12 Q9NYV4 1/20 0.49
PRKAB2 O43741 1/20 0.46
PRKAG1 P54619 1/20 0.46
PRKAA2 P54646 1/20 0.46
PRKAA1 Q13131 1/20 0.46
PRKAG3 Q9UGI9 1/20 0.46
PRKAG2 Q9UGJ0 1/20 0.46
PRKAB1 Q9Y478 1/20 0.46
CCNT1 O60563 1/20 0.42
CCNH P51946 1/20 0.42
PDE10A Q9Y233 1/20 0.38
KDM4E B2RXH2 6/20 0.37
HSD17B10 Q99714 3/20 0.37
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7442948 0.91 CDK9 (0.51) CDK7CDK9CDK2CDK13CDK12
SCHEMBL13288422 0.88 CDK7 (0.46) CDK7CDK9CDK2CDK13CDK12
SCHEMBL7431490 0.87 PRKAB2 (0.54) CDK7CDK9CDK2CDK13CDK12
SCHEMBL11606854 0.82 CDK7 (0.50) CDK7CDK9CDK2CDK13CDK12
SCHEMBL7835034 0.82 PRKAB2 (0.40) CDK7CDK9CDK2CDK13CDK12
SCHEMBL7835395 0.82 PRKAA1 (0.40) CDK7CDK9CDK2CDK13CDK12
SCHEMBL12953048 0.81 PDE10A (0.57) CDK7CDK9CDK2CDK13CDK12
SCHEMBL7847802 0.81 CDK9 (0.52) CDK7CDK9CDK2CDK13CDK12
SCHEMBL19953388 0.80 LOXL2 (0.46) CDK7CDK9CDK2CDK13CDK12
SCHEMBL19288597 0.79 CDK9 (0.41) CDK7CDK9CDK2CDK13CDK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024178067-A9 CHIMERIC DEGRADERS OF CYCLIN-DEPENDENT KINASE 9 AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2025-02-06 WO disclosed
WO-2024178067-A1 CHIMERIC DEGRADERS OF CYCLIN-DEPENDENT KINASE 9 AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2024-08-29 WO disclosed
US-20230158159-A1 CHIMERIC DEGRADERS OF CYCLIN-DEPENDENT KINASE 9 AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2023-05-25 US disclosed
US-20230158159-A1 CHIMERIC DEGRADERS OF CYCLIN-DEPENDENT KINASE 9 AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2023-05-25 US disclosed
US-20230158159-A1 CHIMERIC DEGRADERS OF CYCLIN-DEPENDENT KINASE 9 AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2023-05-25 US disclosed
WO-2021216828-A1 CHIMERIC DEGRADERS OF CYCLIN-DEPENDENT KINASE 9 AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2021-10-28 WO disclosed
WO-2021216828-A1 CHIMERIC DEGRADERS OF CYCLIN-DEPENDENT KINASE 9 AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230158159-A1 CHIMERIC DEGRADERS OF CYCLIN-DEPENDENT KINASE 9 AND USES THEREOF CDK9, CDK19, CRBN CDK7 13/4885CDK9 1/4885CDK2 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.